Orchid Chemicals to acquire U.S. pharma firm
Facebook Twitter google+ RSS Feed

Orchid Chemicals to acquire U.S. pharma firm

Thursday, 30 October 2008, 07:00 Hrs
Printer Print Email Email
Chennai: The city-based bulk drug major Orchid Chemicals and Pharmaceuticals will increase its stake in the American drug discovery and development company Diakron Inc to 51 percent this quarter.

In August, the company acquired around 43 percent control in Diakron on an investment of $1.7 million.

According to an Orchid official, the Indian company will now acquire a controlling interest on a total investment of $2 million.

Orchid Chemicals closed the first half of this fiscal with a revenue of 6.54 billion and a net loss of 723 million, as against 5.29 billion in earnings and 1.14 billion in profits during the corresponding period the previous year.
Source: IANS
Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT